SCHEMBL231300

SCHEMBL231300

COC(=O)c1cc(Oc2ccccc2)cc(C(=NO)c2ccc(N(C)c3ccc(Cl)cc3)cc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
HPGD P15428 1/20 0.40
GFER P55789 1/20 0.40
PGR P06401 1/20 0.39
UTS2R Q9UKP6 1/20 0.39
LTC4S Q16873 3/20 0.38
USP2 O75604 1/20 0.38
ROCK2 O75116 1/20 0.38
RAB9A P51151 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
STAT3 P40763 1/20 0.37
NPC1 O15118 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
ALOX12 P18054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL231299 1.00 ALDH1A1 (0.40) ALDH1A1HPGDGFERPGRUTS2R
SCHEMBL230334 0.90 ALDH1A1 (0.43) ALDH1A1HPGDGFERPGRUTS2R
SCHEMBL230335 0.90 ALDH1A1 (0.43) ALDH1A1HPGDGFERPGRUTS2R
SCHEMBL1727491 0.88 PGR (0.39) ALDH1A1PGRUTS2RLTC4SUSP2
SCHEMBL231253 0.87 LMNA (0.46) ALDH1A1HPGDPGRUTS2RLTC4S
SCHEMBL231166 0.82 STAT3 (0.40) PGRUTS2RLTC4SSTAT3LMNA
SCHEMBL231165 0.82 STAT3 (0.40) PGRUTS2RLTC4SSTAT3LMNA
SCHEMBL10177392 0.82 PGR (0.41) ALDH1A1PGRUTS2RLTC4SRAB9A
SCHEMBL231059 0.79 LTC4S (0.56) LTC4S
SCHEMBL233238 0.77 SRD5A2 (0.51) HPGDPGRUTS2RLTC4SRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406220-A1 BIS AROMATIC COMPOUNDS FOR USE AS LTC4 SYNTHASE INHIBITORS Biolipox AB (SE) 2012-01-18 EP disclosed
US-20120004228-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors BIOLIPOX AB (SW) 2012-01-05 US disclosed
WO-2010103279-A1 BIS AROMATIC COMPOUNDS FOR USE AS LCT4 SYNTHASE INHIBITORS BIOLIPOX AB (SE) 2010-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004228-A1 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors LTC4S, LTB4R2, LTB4R ALDH1A1 453/4885HPGD 169/4885GFER 668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.